124 related articles for article (PubMed ID: 2583066)
1. Suppression of norepinephrine secretion by dopamine in children with neuroblastoma: evidence for precursor inhibition in catecholamine pathway.
Sato T; Minami S; Igarashi N; Miyagawa K
Endocrinol Jpn; 1989 Aug; 36(4):595-603. PubMed ID: 2583066
[TBL] [Abstract][Full Text] [Related]
2. Hormonal activity may predict aggressive behavior in neuroblastoma.
Zambrano E; Reyes-Múgica M
Pediatr Dev Pathol; 2002; 5(2):190-9. PubMed ID: 11910515
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
4. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
[TBL] [Abstract][Full Text] [Related]
5. Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure.
Fukuda S; Kobayashi H; Mochizuki T; Tanaka M; Yokoyama Y; Hattori N
Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1011-7. PubMed ID: 1479729
[TBL] [Abstract][Full Text] [Related]
6. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
Izbicki T; Bozek J; Perek D; Wozniak W
J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a physiological reduction in brain dopamine but not norepinephrine metabolism during the preovulatory phase in normal women.
Paradisi R; Grossi G; Venturoli S; Capelli M; Magrini O; Porcu E; Pasquali R; Flamigni C
Acta Endocrinol (Copenh); 1987 Oct; 116(2):293-8. PubMed ID: 3661067
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
9. Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma.
Brewster MA; Berry DH
Med Pediatr Oncol; 1979; 6(2):93-9. PubMed ID: 460046
[TBL] [Abstract][Full Text] [Related]
10. Urinary free and conjugated catecholamines and metabolites in autistic children.
Barthelemy C; Bruneau N; Cottet-Eymard JM; Domenech-Jouve J; Garreau B; Lelord G; Muh JP; Peyrin L
J Autism Dev Disord; 1988 Dec; 18(4):583-91. PubMed ID: 3215884
[TBL] [Abstract][Full Text] [Related]
11. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
Davidson DF; Hammond PJ; Murphy D; Carachi R
Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of guanethidine on dopamine and norepinephrine pools in urine, heart and superior cervical ganglion in the rat.
Favre R; De Haut M; Boudet C; Dalmaz Y; Cottet-Emard JM; Peyrin L
J Neural Transm; 1987; 70(1-2):19-37. PubMed ID: 3668520
[TBL] [Abstract][Full Text] [Related]
15. Plasma and tumor dopamine-beta-hydroxylase activity in patients with familial pheochromocytomas.
Feldman JM; Blalock JA; Farrell RE; Wells SA
Metabolism; 1978 Dec; 27(12):1797-802. PubMed ID: 723634
[TBL] [Abstract][Full Text] [Related]
16. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine metabolism and disposition in healthy and depressed subjects.
Maas JW; Koslow SH; Davis J; Katz M; Frazer A; Bowden CL; Berman N; Gibbons R; Stokes P; Landis DH
Arch Gen Psychiatry; 1987 Apr; 44(4):337-44. PubMed ID: 3566456
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
19. N-myc oncogene and urinary catecholamines in children with neuroblastoma.
Barontini M; Gutiérrez MI; Levin G; Mur N; Diez B
Med Pediatr Oncol; 1993; 21(7):499-504. PubMed ID: 8341218
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
Lobo RA; Shoupe D; Roy S; Paul W
Am J Obstet Gynecol; 1984 Jul; 149(5):548-52. PubMed ID: 6742025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
